ATOMOXETIN GLENMARK 10 MG CPS DUR 28 I

What is the maximum co-payment for ATOMOXETIN GLENMARK?

If the insurance company contributes, the maximum co-payment is 2 065,94 Kč. The maximum pharmacy price is 2 297,73 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).

Does ATOMOXETIN GLENMARK have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

231,79 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Atomoxetin do síly 60 mg je hrazen u dětí a mladistvých k léčbě hyperkinetické poruchy při neúčinnosti nebo nevhodnosti léčby methylfenidátem. Atomoxetin v síle 40 mg a 60 mg je hrazen rovněž u dospělých pacientů pouze jako iniciační dávka a představuje celkovou denní dávku. Úvodní dávka se má udržovat minimálně 7 dní před titrací dávky směrem nahoru, a to podle klinické odpovědi a snášenlivosti.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe ATOMOXETIN GLENMARK?

psychiatry, child and adolescent psychiatry, geriatric psychiatry

What is the composition of ATOMOXETIN GLENMARK?

Atomoxetin-hydrochlorid (11,428 mg), atomoxetin (10 mg), neznámá látka s kódem 4989, koloidní bezvodý oxid křemičitý, neznámá látka s kódem 379, želatina, natrium-lauryl-sulfát, oxid titaničitý, neznámá látka s kódem 4804, neznámá látka s kódem 20465, černý oxid železitý, propylenglykol. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to ATOMOXETIN GLENMARK?

The medicine belongs to ATC group N06BA09 – ATOMOXETIN. Medicines with the same active substance can be found here.

Who manufactures ATOMOXETIN GLENMARK?

Glenmark Pharmaceuticals s.r.o., Praha (CZ)

Is the medicine in shortage?

The latest report from the manufacturer is from 4. 8. 2025. Production was interrupted as of 31. 8. 2025. The stated reason was: Obchodní/marketingové důvody.
Resumption of supply is expected 18. 5. 2026
The manufacturer lists medicines with the following code as a potential substitute: